TBARS were lower by 23% on day 42 in VC + VE compared to Controls (Table 1)
The rationale for stacking a GHRH analog with a ghrelin-receptor agonist is a theorized synergy : sustained GH elevation (from CJC-1295) plus consistent GH peaks (from Ipamorelin)
Subscribe to save 20% on Jan Marini.
Semaglutide (Ozempic / Wegovy): The Gold Standard GLP-1 Semaglutide is the most widely used GLP-1 medication for weight loss and the one most people have heard of, largely because of Ozempics high-profile advertising and celebrity associations
Donepezil, an acetylcholinesterase inhibitor, has shown promising results in mitigating cardiotoxicity induced by chemotherapeutic agents like doxorubicin and trastuzumab
One important unresolved issue is the limited evidence regarding concomitant use of SGLT2 inhibitors and GLP-1 receptor agonists, a gap also acknowledged in European Society of Cardiology guidelines and Current guidelines prioritize SGLT2 inhibitors in patients with T2DM who have HF, chronic kidney disease, or elevated cardiovascular risk, while GLP-1 receptor agonists are emphasized for patients with obesity or established atherosclerotic cardiovascular disease [7]